Stratakis, Constantine A.
Article History
Accepted: 16 May 2023
First Online: 15 June 2023
Declarations
:
: Dr. Stratakis holds patents on technologies involving PRKAR1A, PDE11A, GPR101 and related genes, and his laboratory has received research funding support by Pfizer Inc., unrelated to this project. Dr. Stratakis currently receives support by ELPEN pharmaceuticals SA, Human Longevity Inc., and has consulted for companies in the last six months on items unrelated to the subject of this report, such as Lundbeck Pharmaceuticals and Sterotherapeutics.
: Non-applicable.